medigraphic.com
ISSN 2448-5640 (Print)
Diario Oficial de la Sociedad Mexicana de Cirugía Cardiaca, A.C., y del Colegio Mexicano de Cirugía Cardiovascular y Torácica, A.C.

2024, Number 1

<< Back Next >>

Cir Card Mex 2024; 9 (1)

Outcomes of extracorporeal membrane oxygenation use in postcardiotomy shock at a single center

Castillo-Romero C, Hernández-Rendón E, Lima-Linares R, Montes de Oca-Sandoval MA, Medina-Concebida LE, Favila-Lira D, Riera-Kinkel C, Ortega-Zhindón DB

Language: English
References: 25
Page: 3-9
PDF size: 1574.83 Kb.


ABSTRACT

Objective. The primary objective of this study was to describe the outcomes of patients who underwent extracorporeal membrane oxygenation (ECMO) following postcardiotomy shock at a single center. Material. In this retrospective study, we reviewed the records of patients who had received post-cardiotomy ECMO therapy from ]uly 1, 2015 to December 31, 2019. The demographic characteristics and perioperative conditions were described. Results. We included 31 patients, 51.6% female. The median age of 26 years (IQR 12-54.5). Postcardiotomy venoarterial ECMO was used in 1.2% of all operations. Congenital procedures were the type of surgical procedure most associated with using ECMO (61.3%). The most common complication was renal failure (35.4%). The median duration of therapy in patients with successful and unsuccessful withdrawals was 5 and 6 days, respectively. Suc-cessful ECMO withdrawal was achieved in 38.7% of patients and 29.1 % at hospital discharge. Cardiogenic shock was the most prevalent cause of death (54.8%). Conclusions. ECMO contributes to improved outcomes in cases where alternative supportive measures are inadequate. The results from our center are similar to published reports supporting the use of postcardiotomy ECMO therapy as a feasible option for criti-cally ill patients


REFERENCES

  1. Fux T, Holm M, Corbascio M, Lund LH, van der Linden J. Venoarterial extracorporealmembrane oxygenation for postcardiotomy shock: Risk factors for mortality.J Thorac Cardiovasc Surg. 2018;156(5):1894-1902.

  2. Meani P, Matteucci M, Jiritano F, et al. Long-term survival and major outcomes inpost-cardiotomy extracorporeal membrane oxygenation for adult patients in cardiogenicshock. Ann Cardiothorac Surg 2019;8:116-122.

  3. Kowalewski M, Raffa GM, Zieliński K, et al. The impact of Centre's heart transplantstatus and volume on in-hospital outcomes following extracorporeal membraneoxygenation for refractory post-cardiotomy cardiogenic shock: a meta-analysis.BMC Cardiovasc Disord 2020;20:10.

  4. Caneo LF, Jatene MB. Pediatric mechanical circulatory support systems in LatinAmerica. Artif Organs 2016;40:925-928.

  5. Vargas-Camacho G, Contreras-Cepeda V, Gómez-Gutierrez R, et al. Venoarterialextracorporeal membrane oxygenation in heart surgery postoperative pediatric patients:a retrospective study at Christus Muguerza Hospital, Monterrey, Mexico.SAGE Open Med 2020;8.

  6. Shakoor A, Pedroso FE, Jacobs SE, et al. Extracorporeal cardiopulmonary resuscitation(ECPR) in infants and children: a single-center retrospective study. WorldJ Pediatr Congenit Heart Surg 2019;10:582-589.

  7. Choi MS, Sung K, Cho YH. Clinical pearls of venoarterial extracorporeal membraneoxygenation for cardiogenic shock. Korean Circ J 2019;49:657-677.

  8. Khorsandi M, Dougherty S, Sinclair A, et al. A 20-year multicentre outcome analysisof salvage mechanical circulatory support for refractory cardiogenic shockafter cardiac surgery. J Cardiothorac Surg 2016;11:151.

  9. Brogan TV, Lequier L, Lorusso R, MacLaren G, Peek G. Extracorporeal life support:the ELSO red book. 5th ed. Ann Arbor, MI, USA: Extracorporeal Life SupportOrganization, 2017.

  10. Extracorporeal Life Support Organization. ELSO guidelines for circulatory/cardiacsupport. [Consult: July 4, 2023]. Available in: https://www.elso.org/ecmo-resources/elso-ecmo-guidelines.aspx.

  11. Lorusso R, Whitman G, Milojevic M, et al. 2020 EACTS/ELSO/STS/AATS expertconsensus on post-cardiotomy extracorporeal life support in adult patients.Eur J Cardiothorac Surg. 2021;59(1):12-53.

  12. Douflé G, Roscoe A, Billia F, Fan E. Echocardiography for adult patients supportedwith extracorporeal membrane oxygenation. Crit Care 2015;19: 326.

  13. Soleimani B, Pae WE. Management of left ventricular distension during peripheralextracorporeal membrane oxygenation for cardiogenic shock. Perfusion2012;27:326-331.

  14. Khorsandi M, Davidson M, Bouamra O, et al. Extracorporeal membrane oxygenationin pediatric cardiac surgery: a retrospective review of trends and outcomesin Scotland. Ann Pediatr Cardiol 2018;11:3-11.

  15. Riley JB, Schears GJ, Nuttall GA, Oliver Jr WC, Ereth MH, Dearani JA. Coagulationparameter thresholds associated with non-bleeding in the eighth hour of adultcardiac surgical post-cardiotomy extracorporeal membrane oxygenation. J ExtraCorpor Technol 2016;48:71-78.

  16. Kilburn DJ, Shekar K, Fraser JF. The complex relationship of extracorporealmembrane oxygenation and acute kidney injury: causation or association? BiomedRes Int 2016;2016:1094296.

  17. Pabst D, Sanchez-Cueva PA, Soleimani B, Brehm CE. Predictors for acute andchronic renal failure and survival in patients supported with veno-arterial extracorporealmembrane oxygenation. Perfusion 2019;35:402-408.

  18. Ostermann M, Connor M, Kashani K. Continuous renal replacement therapyduring extracorporeal membrane oxygenation. Curr Opin Crit Care 2018;24:493-503.

  19. Guihaire J, Dang Van S, Rouze S, et al. Clinical outcomes in patients after extracorporealmembrane oxygenation support for post-cardiotomy cardiogenicshock: a single-centre experience of 92 cases. Interact Cardiovasc Thorac Surg

  20. 2017;25:363-369.20. Silvetti S, Ranucci M, Pistuddi V, et al. Bloodstream infections during post-cardiotomyextracorporeal membrane oxygenation: incidence, risk factors, and outcomes.Int J Artif Organs 2019;42:299-306.

  21. Omar HR, Mirsaeidi M, Socias S, et al. Plasma free hemoglobin is an independentpredictor of mortality among patients on extracorporeal membrane oxygenationsupport. PLoS One 2015;10: e0124034.

  22. Okochi S, Cheung EW, Barton S, et al. An analysis of risk factors for hemolysisin children on extracorporeal membrane oxygenation. Pediatr Crit Care Med2018;19:1059-1066.

  23. Lo Coco V, Lorusso R, Raffa GM, et al. Clinical complications during veno-arterialextracorporeal membrane oxigenation in post-cardiotomy and non post-cardiotomyshock: still the achille's heel. J Thorac Dis 2018;10:6993-7004.

  24. McCarthy FH, McDermott KM, Kini V, et al. Trends in U.S. extracorporeal membraneoxygenation use and outcomes: 2002-2012. Semin Thorac Cardiovasc Surg2015;27:81-88.

  25. Whitman GJR. Extracorporeal membrane oxygenation for the treatment of postcardiotomyshock. J Thorac Cardiovasc Surg 2017;153:95-101.




2020     |     www.medigraphic.com